Tech Transfer Summit Russia 2010 Confirmed Speakers
Alexey Konov, CEO, Bioprocess Investment, Russia
Ann Hammersla, Director – Division of Policy, Office of Technology Transfer, National Institutes of Health, USA
Anne Lane, Director, Biopharm, UCL, U.K.
Claes Post, Business Development, Linkoping University Innovation, Sweden
Dr. Yin Li, Institute of Microbiology, Chinese Academy of Sciences, China
Elena Lurie Luke, Director, Bioscience Business Development, Procter & Gamble, U.K (t.b.c.)
Hicham Abghay, Chair – Healthcare, Enterprise Europe Network, Steinbeis Foundation, Germany
Igor Goryanov, Innograd “Skolkovo”, Russia
Igor Krasilnikov, Head of Department, FGUP “ NPO Microgen”, Russia
Ilgyzar Yakushev, Deputy General director, OAO Tatneftecheminvestholding”, Republic of Tatarstan, Russia
Ilya Klebanov, President's Plenipotentiary in the North-West Federal District, Russia
Isabell von Korff, Ascenion GmbH, Germany
John Claxton, Deputy Head of Unit Biotechnologies, Food & Agriculture, Directorate General for Research, European Commission
Kevin Noonan, Partner, McDonnell Boehnen Hulbert & Berghoff, USA
Lorne Meikle, CEO, Life Sciences Ontario, Canada
Louise Sarup, Director, IP-Pragmatics, U.K.
Manfred Horst, Business Development, Merck & Co., France
Matthieu Coutet, Investment Manager, Inserm Transfert, France
Maxim Uvarov, CEO, Binnopharm, Russia
Morton Juhl-Corydon, Director Licensing, Novozymes. Denmark (t.b.c.)
Patrick Tricoli, Global Head Scouting & Partnering, Sanofi-Aventis, France
Paul Tully, Partner, MBHB, Chicago, USA
Pavel Savitsky, Senior Associate, Mannheimer Swartling, Russia
Pedro Noronha de Pissarra, Chairman & CEO, Biotecnol SA, Portugal & USA
Raif Vasilov, President, Russian BioIndustry Association & President, Federation of Asian BioIndustry Associations.
Sam Ogunsalu, Principal Executive Commercial Development, Queen Mary University, U.K.
Seppo Makinen, ex-Managing Partner BioFund & CapiNordic, Finland
Sergey Kalyuzhny, Member of the Board, RUSNANO, Russia
Sergey Kryukov, Chairman of the Board of Directors, ROAO ”Rosagrobioprem”, Russia
Sigurgeir Gudlaugsson, CEO, Citalfort Consulting, Board Member Actavis Pharma, Iceland
Stéphane Hogan, Head of Unit, Coordination, Health Directorate General for Research, European Commission
Stuart Henderson, Partner & Head of Healthcare & Life Sciences Europe, Deloitte, U.K.
Thomas Westphal, Partner, Glawe Delfs Moll, Germany
Tony Jones, Director, One Nucleus, UK
Valentina Matvienko, Governor of Saint Petersburg, Russia
Valery Chereshnev, Chairman of the Committee of the State Duma, Russia
Vladimir Popov, A.N. Bakh Institute of Biochemistry, RAS, Head of the Russian National Contact Point on FP7-TP2 Food, Agriculture and Biotechnology, Russia
Vyacheslav Trubnikov, Chairman of the Board, Russian BioIndustry Association, former First Deputy Foreign Minister of the Russian Federation, former Ambassador of the Russian Federation to India
Yury Oreshin, Teknoinvest Angelico Ventures, Russia
Yury Voloshin, Deputy Prime Minister of Chuvash Republic, Russia